Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema and CRVO
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Prospective interventional study on 60 eyes of resistant diabetic macular edema and central
retinal vein occlusion that will receive suprachoroidal injection of Triamcinolone Acetonide
(SCTA).